로딩 중…
StockDiggingStockDigging

Sam-A Pharm. Co., Ltd

009300· KOSDAQ
₩13,330-3.48%
2026-06-19

Price Chart

Sam-A Pharm. Co., Ltd-23.83%

Financials

Investment Metrics(as of 2026-06-19)

MetricValue
Size
Market Cap84.91B KRW
Revenue70.93B KRW
Net Income3.98B KRW
Total Assets247.04B KRW
Net Assets228.11B KRW
Employees316
Value
P/E21.32x
P/B0.37x
P/S1.20x
FCF Yield11.02%
Profitability
ROE1.75%
ROA1.61%
Op. Margin-3.81%
Revenue Growth-28.05%
Earnings Growth-64.71%
Financial Health
Debt Ratio8.30%
Total Debt1.14B KRW
FCF9.35B KRW
Cash14.67B KRW
Current Ratio7.79x
Dividend
Div. Yield6.16%
Div. Growth6.25%
Performance
1Y Return-23.83%
1M Return-14.61%
From 52W High-30.75%
1Y MDD-32.23%
Trading
Volume4,528 shares
Foreign Own.1.43%
Per Share
EPS1,395 KRW
BPS37,011 KRW

Company Info

CEO 허 준
Employees 316
Founded 1973
HQ 강원도 원주시, KR

Sama Pharmaceutical, founded as Bogun Pharmaceutical Laboratory in 1945 and incorporated in 1973, was listed on KOSDAQ in 2000. It manufactures and sells a wide range of pharmaceuticals, including respiratory, antibiotic, dermatological, and digestive system drugs, with key products like Citoos, Codenal, Hebron, and Setofen. The company completed its Munmak factory as a KGMP pharmaceutical production facility in 2009 and continues to develop differentiated generic products through new drug and new product research and development. Sama Pharmaceutical is headquartered in Wonju-si, Gangwon-do.